After signing up, you'll start to receive regular news updates from us.
European Union Powers Ahead with €12 Million Funding for Human Embryonic Stem Cell Research Consortium
Complete the form below to unlock access to ALL audio articles.
Stem Cell Sciences has announced that it will participate in the European Commission approved "ESTOOLS" program, a world leading euro 12 million human embryonic stem cell research initiative involving both academic and commercial researchers. Stem Cell Sciences is one of three commercial partners taking part in this program.
"SCS is bringing its technologies and expertise to the project, and plans to use discoveries to supply improved cell based drug screening and toxicology options to the pharmaceutical and biotechnology industries," said Dr Lilian Hook, Scientific Program Manager - Europe.
"In the longer term, all these technologies will mesh to help us deliver new stem cell therapies."
"The momentum for embryonic stem cell research and development is growing, and this funding to will greatly enhance our competitive advantage in delivering human embryonic stem cell based products to the market," commented Dr. Peter Mountford, CEO of Stem Cell Sciences.
"We're delighted that the European Union has elected to fund wide-ranging research in this controversial field."
"It is a decision that compares very favorably to the situation in the USA where research is still being hampered by political factors and this specific field of endeavor is directly aligned with our commercial focus."
